Neuronal Plasticity-Dependent Paradigm and Young Plasma Treatment Prevent Synaptic and Motor Deficit in a Rett...

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 gene mutations, leading to impaired gene expression control and severe phenotypes.
• Mouse models lacking Mecp2 expression mimic RTT, serving as crucial tools for therapeutic research.
• Environmental enrichment (EE) is known to alleviate RTT symptoms, but the underlying mechanisms remain unclear.

Purpose of the Study:

• To investigate the mechanisms by which EE ameliorates RTT phenotypes in Mecp2-null mice.
• To explore the potential of plasma-based therapies, mimicking EE benefits, for RTT treatment.

Main Methods:

• Housing Mecp2-null and wild-type mice in enriched environments designed for sensory, cognitive, social, and motor stimulation.
• Assessing the impact of EE on neuronal cytoarchitecture, neural plasticity, and neuromuscular junction organization.
• Administering plasma from young wild-type mice to Mecp2-null mice to evaluate its therapeutic effects.

Main Results:

• EE preserved neuronal cytoarchitecture and neural plasticity markers in Mecp2-null mice.
• EE ameliorated neuromuscular junction defects and restored motor function in RTT mouse models.
• Plasma treatment from young wild-type mice attenuated RTT phenotypes by improving neurological markers, suggesting peripheral signal involvement.

Conclusions:

• Environmental enrichment effectively mitigates RTT progression by maintaining neuronal integrity and plasticity.
• Peripheral factors, potentially modulated by EE or present in young wild-type plasma, can positively influence neurodevelopment in RTT.
• EE and young plasma therapy represent promising, novel therapeutic strategies for Rett syndrome.